

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.68105210 |
| 2 | negative T cell selection (GO:0043383) | 5.64072959 |
| 3 | negative thymic T cell selection (GO:0045060) | 5.47400222 |
| 4 | cellular response to interleukin-15 (GO:0071350) | 5.29989766 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21963659 |
| 6 | positive thymic T cell selection (GO:0045059) | 4.89121900 |
| 7 | positive T cell selection (GO:0043368) | 4.88714356 |
| 8 | response to interleukin-15 (GO:0070672) | 4.84910746 |
| 9 | leukocyte aggregation (GO:0070486) | 4.79128340 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.67406491 |
| 11 | T cell migration (GO:0072678) | 4.66838925 |
| 12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.66672744 |
| 13 | thymic T cell selection (GO:0045061) | 4.55527316 |
| 14 | interferon-gamma production (GO:0032609) | 4.50188023 |
| 15 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.43463746 |
| 16 | T cell selection (GO:0045058) | 4.39009921 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.38798230 |
| 18 | response to peptidoglycan (GO:0032494) | 4.27441083 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.12931390 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.09654251 |
| 21 | regulation of mononuclear cell migration (GO:0071675) | 4.09311216 |
| 22 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.02490258 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.99647825 |
| 24 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.98839929 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.97768968 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.97768968 |
| 27 | positive regulation of humoral immune response (GO:0002922) | 3.93654926 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.90773619 |
| 29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.88649460 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85880794 |
| 31 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.84016340 |
| 32 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.84016340 |
| 33 | T-helper 1 type immune response (GO:0042088) | 3.81794820 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80064741 |
| 35 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.76308974 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.68606851 |
| 37 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.68417459 |
| 38 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.68417459 |
| 39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.67702772 |
| 40 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.67437171 |
| 41 | positive regulation of interleukin-2 production (GO:0032743) | 3.66540269 |
| 42 | positive regulation of B cell mediated immunity (GO:0002714) | 3.61215356 |
| 43 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.61215356 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60213571 |
| 45 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.58691883 |
| 46 | T-helper cell differentiation (GO:0042093) | 3.55336046 |
| 47 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.55336046 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 3.55006414 |
| 49 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.54662009 |
| 50 | tolerance induction (GO:0002507) | 3.50601206 |
| 51 | cellular extravasation (GO:0045123) | 3.48751196 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.46548068 |
| 53 | T cell receptor signaling pathway (GO:0050852) | 3.45943686 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45703417 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45703417 |
| 56 | granulocyte activation (GO:0036230) | 3.45053692 |
| 57 | natural killer cell activation (GO:0030101) | 3.44884459 |
| 58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.43538401 |
| 59 | T cell costimulation (GO:0031295) | 3.41344990 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 3.41272333 |
| 61 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.40136361 |
| 62 | lymphocyte costimulation (GO:0031294) | 3.39295662 |
| 63 | positive regulation of cell killing (GO:0031343) | 3.38980451 |
| 64 | monocyte chemotaxis (GO:0002548) | 3.33408112 |
| 65 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.31620017 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31522260 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 3.29622251 |
| 68 | positive regulation by symbiont of host defense response (GO:0052509) | 3.27773677 |
| 69 | modulation by symbiont of host defense response (GO:0052031) | 3.27773677 |
| 70 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.27773677 |
| 71 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.27773677 |
| 72 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.27773677 |
| 73 | modulation by symbiont of host immune response (GO:0052553) | 3.27773677 |
| 74 | regulation of cell killing (GO:0031341) | 3.27261292 |
| 75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.26720921 |
| 76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26486908 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 3.26041545 |
| 78 | positive regulation of T cell cytokine production (GO:0002726) | 3.24947574 |
| 79 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24451321 |
| 80 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.23249644 |
| 81 | regulation of hypersensitivity (GO:0002883) | 3.23192377 |
| 82 | positive regulation of isotype switching (GO:0045830) | 3.23021993 |
| 83 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.22770941 |
| 84 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.22360124 |
| 85 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.22360124 |
| 86 | T cell differentiation involved in immune response (GO:0002292) | 3.22360124 |
| 87 | lymphocyte chemotaxis (GO:0048247) | 3.21010579 |
| 88 | myeloid cell activation involved in immune response (GO:0002275) | 3.20998613 |
| 89 | positive regulation of interleukin-17 production (GO:0032740) | 3.20925803 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 3.20369760 |
| 91 | regulation of podosome assembly (GO:0071801) | 3.19910813 |
| 92 | positive regulation of DNA recombination (GO:0045911) | 3.18810343 |
| 93 | regulation of B cell mediated immunity (GO:0002712) | 3.14001326 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.12748069 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12466734 |
| 96 | regulation of immunoglobulin secretion (GO:0051023) | 3.11805962 |
| 97 | germinal center formation (GO:0002467) | 3.10415804 |
| 98 | mast cell activation (GO:0045576) | 3.09695591 |
| 99 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.07619024 |
| 100 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07061671 |
| 101 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.06659703 |
| 102 | neutrophil activation (GO:0042119) | 3.06613899 |
| 103 | positive regulation of interferon-gamma production (GO:0032729) | 3.06177430 |
| 104 | glycosphingolipid catabolic process (GO:0046479) | 3.06171334 |
| 105 | barbed-end actin filament capping (GO:0051016) | 3.05181688 |
| 106 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.03299354 |
| 107 | activated T cell proliferation (GO:0050798) | 3.02807313 |
| 108 | regulation of macrophage chemotaxis (GO:0010758) | 3.01249820 |
| 109 | oligosaccharide catabolic process (GO:0009313) | 3.01094310 |
| 110 | regulation of interleukin-2 production (GO:0032663) | 3.01068203 |
| 111 | regulation of isotype switching (GO:0045191) | 3.00795289 |
| 112 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.00777334 |
| 113 | alpha-beta T cell differentiation (GO:0046632) | 3.00533383 |
| 114 | sequestering of actin monomers (GO:0042989) | 2.99733521 |
| 115 | alpha-beta T cell activation (GO:0046631) | 2.99510812 |
| 116 | positive regulation of heat generation (GO:0031652) | 2.99278529 |
| 117 | amino sugar catabolic process (GO:0046348) | 2.99137452 |
| 118 | regulation of memory T cell differentiation (GO:0043380) | 2.97143808 |
| 119 | response to type I interferon (GO:0034340) | 2.96424347 |
| 120 | response to protozoan (GO:0001562) | 2.94694016 |
| 121 | T cell activation involved in immune response (GO:0002286) | 2.94597755 |
| 122 | cellular response to type I interferon (GO:0071357) | 2.94499404 |
| 123 | type I interferon signaling pathway (GO:0060337) | 2.94499404 |
| 124 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.94397948 |
| 125 | positive regulation of mast cell activation (GO:0033005) | 2.92548151 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91847810 |
| 127 | positive regulation of macrophage differentiation (GO:0045651) | 2.91710816 |
| 128 | response to muramyl dipeptide (GO:0032495) | 2.91403340 |
| 129 | positive regulation of mast cell degranulation (GO:0043306) | 2.91054492 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.91054492 |
| 131 | T cell homeostasis (GO:0043029) | 2.89117224 |
| 132 | lymphocyte migration (GO:0072676) | 2.88654979 |
| 133 | regulation of chemokine biosynthetic process (GO:0045073) | 2.88556027 |
| 134 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.88170883 |
| 135 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87967398 |
| 136 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.86923215 |
| 137 | defense response to protozoan (GO:0042832) | 2.86901822 |
| 138 | regulation of chronic inflammatory response (GO:0002676) | 2.86161793 |
| 139 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.84253663 |
| 140 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.83050165 |
| 141 | leukocyte degranulation (GO:0043299) | 2.82739320 |
| 142 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.81856489 |
| 143 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.80126157 |
| 144 | positive regulation of activated T cell proliferation (GO:0042104) | 2.79991124 |
| 145 | regulation of mast cell activation (GO:0033003) | 2.79806172 |
| 146 | leukocyte cell-cell adhesion (GO:0007159) | 2.78075831 |
| 147 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.77954173 |
| 148 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.77703133 |
| 149 | regulation of leukocyte degranulation (GO:0043300) | 2.76951065 |
| 150 | negative regulation of innate immune response (GO:0045824) | 2.73201010 |
| 151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.73017267 |
| 152 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72930513 |
| 153 | glycolipid catabolic process (GO:0019377) | 2.72460668 |
| 154 | regulation of fever generation (GO:0031620) | 2.71847635 |
| 155 | cellular response to lipopolysaccharide (GO:0071222) | 2.71070339 |
| 156 | regulation of lymphocyte migration (GO:2000401) | 2.70870134 |
| 157 | neutrophil chemotaxis (GO:0030593) | 2.69454316 |
| 158 | cellular response to arsenic-containing substance (GO:0071243) | 2.68984626 |
| 159 | regulation of vitamin metabolic process (GO:0030656) | 2.68624417 |
| 160 | cellular defense response (GO:0006968) | 2.67462069 |
| 161 | eosinophil chemotaxis (GO:0048245) | 2.66871262 |
| 162 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66367271 |
| 163 | macrophage chemotaxis (GO:0048246) | 2.66308777 |
| 164 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.65436264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.19742610 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.95954689 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.49333330 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.34312764 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.77102177 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.76546163 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68686264 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.60390128 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.40858494 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99066541 |
| 11 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94896075 |
| 12 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70884619 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.42423428 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38474613 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34558768 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.30770719 |
| 17 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27935816 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.23595632 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.17567919 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14044359 |
| 21 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.09231873 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05435216 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04472396 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03328899 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99400491 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98688508 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98336744 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94298725 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.93719987 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.90254901 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85115997 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82953619 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81554896 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80253525 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77956480 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74032459 |
| 37 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.70345137 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66702009 |
| 39 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63684710 |
| 40 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62243644 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60195191 |
| 42 | * MYC_22102868_ChIP-Seq_BL_Human | 1.56137542 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.53995696 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46786881 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46597371 |
| 46 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46574452 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46261988 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45584469 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43912594 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43882651 |
| 51 | * MYB_26560356_Chip-Seq_TH1_Human | 1.43060728 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42098859 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39902382 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38234991 |
| 55 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36940389 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33779782 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33583606 |
| 58 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.33147157 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33144763 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32979369 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31882354 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31384179 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30632431 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29962601 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29446809 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29273357 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29111196 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28646984 |
| 69 | * MAF_26560356_Chip-Seq_TH1_Human | 1.27913365 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26819742 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26684806 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26455489 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25838119 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23618022 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23616850 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23218355 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22564656 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22487840 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21750025 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21252840 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20426168 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20382783 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19947358 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19382953 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18351752 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17895488 |
| 87 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17749824 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17553047 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17397114 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16020142 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15240355 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14595070 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14462301 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13507041 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13105749 |
| 96 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12800737 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12794545 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12551969 |
| 99 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11622351 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11206926 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10505970 |
| 102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10278667 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08734239 |
| 104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07640200 |
| 105 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07234483 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04799343 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04714197 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04379329 |
| 109 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.04086817 |
| 110 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03943573 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03720682 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03478710 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03387965 |
| 114 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03360174 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02968309 |
| 116 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.02599032 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02398429 |
| 118 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01722411 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01030573 |
| 120 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00405923 |
| 121 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00399496 |
| 122 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99716683 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99173919 |
| 124 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98334630 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97555623 |
| 126 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97249492 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97193829 |
| 128 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.96265447 |
| 129 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.94374221 |
| 130 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93695150 |
| 131 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93695150 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93571456 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92477039 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92023505 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91723526 |
| 136 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91261301 |
| 137 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90979571 |
| 138 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90616282 |
| 139 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90553627 |
| 140 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90533181 |
| 141 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.89992546 |
| 142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89660304 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89408190 |
| 144 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88862354 |
| 145 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.88187569 |
| 146 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.87853021 |
| 147 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87037332 |
| 148 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86956177 |
| 149 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.86105543 |
| 150 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.85718643 |
| 151 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.85122206 |
| 152 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.85106516 |
| 153 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84699680 |
| 154 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.83707070 |
| 155 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83471451 |
| 156 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83329028 |
| 157 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82769393 |
| 158 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82463575 |
| 159 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81282941 |
| 160 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.80387728 |
| 161 | AR_25329375_ChIP-Seq_VCAP_Human | 0.79755900 |
| 162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79128497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.62726137 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.75925702 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.66561263 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.43979971 |
| 5 | MP0000685_abnormal_immune_system | 3.28989819 |
| 6 | MP0009785_altered_susceptibility_to | 3.24042053 |
| 7 | MP0005387_immune_system_phenotype | 3.07139951 |
| 8 | MP0001790_abnormal_immune_system | 3.07139951 |
| 9 | MP0009840_abnormal_foam_cell | 3.05799062 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.75085370 |
| 11 | MP0001800_abnormal_humoral_immune | 2.65352385 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.55618037 |
| 13 | MP0002723_abnormal_immune_serum | 2.49923721 |
| 14 | MP0005025_abnormal_response_to | 2.46734170 |
| 15 | MP0006082_CNS_inflammation | 2.45089656 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.43524535 |
| 17 | MP0003724_increased_susceptibility_to | 2.42948633 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.40086025 |
| 19 | * MP0001819_abnormal_immune_cell | 2.39536773 |
| 20 | MP0002006_tumorigenesis | 2.38771537 |
| 21 | * MP0002452_abnormal_antigen_presenting | 2.26785025 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.25730639 |
| 23 | MP0003436_decreased_susceptibility_to | 2.23727596 |
| 24 | MP0000343_altered_response_to | 2.15044092 |
| 25 | MP0009278_abnormal_bone_marrow | 2.07364661 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.03471366 |
| 27 | MP0004381_abnormal_hair_follicle | 2.02741150 |
| 28 | * MP0002419_abnormal_innate_immunity | 2.01251121 |
| 29 | MP0004510_myositis | 1.99107260 |
| 30 | MP0002405_respiratory_system_inflammati | 1.99100679 |
| 31 | MP0002009_preneoplasia | 1.95372036 |
| 32 | MP0002398_abnormal_bone_marrow | 1.95087039 |
| 33 | MP0001873_stomach_inflammation | 1.92630881 |
| 34 | MP0003075_altered_response_to | 1.91347332 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.86810382 |
| 36 | MP0003787_abnormal_imprinting | 1.85754343 |
| 37 | * MP0000716_abnormal_immune_system | 1.85490846 |
| 38 | MP0000604_amyloidosis | 1.85172093 |
| 39 | MP0002933_joint_inflammation | 1.79115648 |
| 40 | MP0003880_abnormal_central_pattern | 1.75427385 |
| 41 | MP0004947_skin_inflammation | 1.74728866 |
| 42 | MP0005310_abnormal_salivary_gland | 1.71516001 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.67684222 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.67238351 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.59601468 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.53760330 |
| 47 | MP0003866_abnormal_defecation | 1.52269814 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.51336279 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.49677605 |
| 50 | MP0002722_abnormal_immune_system | 1.46666221 |
| 51 | MP0002163_abnormal_gland_morphology | 1.44365248 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.43390274 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.40088171 |
| 54 | MP0003690_abnormal_glial_cell | 1.38511498 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.37427839 |
| 56 | MP0005451_abnormal_body_composition | 1.37408496 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.37238524 |
| 58 | MP0001853_heart_inflammation | 1.36982356 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.34856633 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.34856633 |
| 61 | * MP0002429_abnormal_blood_cell | 1.33576519 |
| 62 | MP0006054_spinal_hemorrhage | 1.29645173 |
| 63 | MP0005166_decreased_susceptibility_to | 1.24850721 |
| 64 | MP0002822_catalepsy | 1.21828180 |
| 65 | MP0009764_decreased_sensitivity_to | 1.16278656 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.15880723 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.12547075 |
| 68 | MP0006292_abnormal_olfactory_placode | 1.12228438 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.11984919 |
| 70 | * MP0003448_altered_tumor_morphology | 1.11702821 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.10995919 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.09804601 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.08904329 |
| 74 | MP0005390_skeleton_phenotype | 1.08830028 |
| 75 | MP0003828_pulmonary_edema | 1.08370228 |
| 76 | MP0002132_abnormal_respiratory_system | 1.08316910 |
| 77 | MP0000920_abnormal_myelination | 1.08088195 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.07207532 |
| 79 | MP0001188_hyperpigmentation | 1.04893020 |
| 80 | MP0005646_abnormal_pituitary_gland | 1.04427274 |
| 81 | MP0005423_abnormal_somatic_nervous | 1.03476301 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.02816575 |
| 83 | MP0004742_abnormal_vestibular_system | 1.02785361 |
| 84 | MP0003300_gastrointestinal_ulcer | 1.02598025 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.01497718 |
| 86 | MP0010386_abnormal_urinary_bladder | 1.00937661 |
| 87 | MP0003136_yellow_coat_color | 1.00136825 |
| 88 | MP0001851_eye_inflammation | 0.99792477 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.98950551 |
| 90 | * MP0002998_abnormal_bone_remodeling | 0.98844973 |
| 91 | MP0005164_abnormal_response_to | 0.98754105 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.97990841 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.97678216 |
| 94 | MP0000858_altered_metastatic_potential | 0.97049335 |
| 95 | MP0005171_absent_coat_pigmentation | 0.96319843 |
| 96 | MP0000372_irregular_coat_pigmentation | 0.96209215 |
| 97 | MP0009763_increased_sensitivity_to | 0.96020668 |
| 98 | MP0003303_peritoneal_inflammation | 0.94216638 |
| 99 | MP0003329_amyloid_beta_deposits | 0.93203022 |
| 100 | MP0002254_reproductive_system_inflammat | 0.89955265 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.89813047 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.88943652 |
| 103 | MP0001542_abnormal_bone_strength | 0.88313482 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.87761687 |
| 105 | MP0008469_abnormal_protein_level | 0.87523534 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.87380993 |
| 107 | * MP0003795_abnormal_bone_structure | 0.87001022 |
| 108 | MP0005023_abnormal_wound_healing | 0.86869615 |
| 109 | MP0008260_abnormal_autophagy | 0.84744446 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.83763161 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.82814169 |
| 112 | MP0002736_abnormal_nociception_after | 0.82234885 |
| 113 | MP0008004_abnormal_stomach_pH | 0.80982420 |
| 114 | MP0009046_muscle_twitch | 0.80919438 |
| 115 | MP0003279_aneurysm | 0.80536141 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.79977645 |
| 117 | MP0009745_abnormal_behavioral_response | 0.79616580 |
| 118 | MP0001346_abnormal_lacrimal_gland | 0.78729513 |
| 119 | MP0005165_increased_susceptibility_to | 0.77655637 |
| 120 | MP0000249_abnormal_blood_vessel | 0.76797828 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.75367877 |
| 122 | MP0001663_abnormal_digestive_system | 0.75262602 |
| 123 | MP0003045_fibrosis | 0.71326153 |
| 124 | MP0003091_abnormal_cell_migration | 0.71039080 |
| 125 | MP0004883_abnormal_blood_vessel | 0.70530382 |
| 126 | MP0000371_diluted_coat_color | 0.69657778 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.68466847 |
| 128 | MP0002638_abnormal_pupillary_reflex | 0.68352361 |
| 129 | MP0001968_abnormal_touch/_nociception | 0.66755261 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.65221936 |
| 131 | MP0008874_decreased_physiological_sensi | 0.64398100 |
| 132 | MP0002102_abnormal_ear_morphology | 0.62705263 |
| 133 | MP0008569_lethality_at_weaning | 0.62185926 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.61019085 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.60803553 |
| 136 | MP0001529_abnormal_vocalization | 0.60740077 |
| 137 | MP0002064_seizures | 0.60317979 |
| 138 | MP0006276_abnormal_autonomic_nervous | 0.57587359 |
| 139 | MP0000569_abnormal_digit_pigmentation | 0.57408409 |
| 140 | MP0001984_abnormal_olfaction | 0.56409639 |
| 141 | MP0005409_darkened_coat_color | 0.56282077 |
| 142 | MP0000490_abnormal_crypts_of | 0.55885898 |
| 143 | MP0002572_abnormal_emotion/affect_behav | 0.55231060 |
| 144 | MP0003634_abnormal_glial_cell | 0.55051735 |
| 145 | MP0000609_abnormal_liver_physiology | 0.54229319 |
| 146 | MP0003879_abnormal_hair_cell | 0.52502908 |
| 147 | MP0003195_calcinosis | 0.49544669 |
| 148 | MP0001216_abnormal_epidermal_layer | 0.47341674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.32947839 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.32947839 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.32947839 |
| 4 | Stomatitis (HP:0010280) | 5.08281824 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.00358111 |
| 6 | Optic neuritis (HP:0100653) | 4.98726106 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.98726106 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.74799952 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.69638612 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.55171681 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 4.55171681 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.51814386 |
| 13 | T lymphocytopenia (HP:0005403) | 4.47075185 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.37919919 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.37309579 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.29399591 |
| 17 | Severe combined immunodeficiency (HP:0004430) | 4.28679212 |
| 18 | Myositis (HP:0100614) | 4.27120726 |
| 19 | Recurrent abscess formation (HP:0002722) | 4.07200000 |
| 20 | Increased IgM level (HP:0003496) | 4.04678039 |
| 21 | Loss of speech (HP:0002371) | 4.04461876 |
| 22 | Orchitis (HP:0100796) | 3.96361077 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.82628596 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.65573778 |
| 25 | Chronic diarrhea (HP:0002028) | 3.65352176 |
| 26 | Combined immunodeficiency (HP:0005387) | 3.55250725 |
| 27 | Disinhibition (HP:0000734) | 3.44158823 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.42345709 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.37283592 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.37283592 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.37283592 |
| 32 | Neurofibrillary tangles (HP:0002185) | 3.26924663 |
| 33 | Mutism (HP:0002300) | 3.25974217 |
| 34 | Mucopolysacchariduria (HP:0008155) | 3.20230152 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.20230152 |
| 36 | Chronic otitis media (HP:0000389) | 3.19515985 |
| 37 | Abnormality of T cells (HP:0002843) | 3.19431971 |
| 38 | Pustule (HP:0200039) | 3.16707608 |
| 39 | Recurrent bronchitis (HP:0002837) | 3.12601846 |
| 40 | IgG deficiency (HP:0004315) | 3.08649250 |
| 41 | Abnormality of eosinophils (HP:0001879) | 3.08267896 |
| 42 | Vasculitis (HP:0002633) | 3.07086080 |
| 43 | Cheilitis (HP:0100825) | 3.05385886 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04007115 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 3.00953388 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.98328079 |
| 47 | Recurrent viral infections (HP:0004429) | 2.96599730 |
| 48 | Thyroiditis (HP:0100646) | 2.96556477 |
| 49 | Lymphopenia (HP:0001888) | 2.95224980 |
| 50 | Hemoptysis (HP:0002105) | 2.93694824 |
| 51 | Axonal loss (HP:0003447) | 2.92953714 |
| 52 | Recurrent bacterial skin infections (HP:0005406) | 2.92412388 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.90925927 |
| 54 | Recurrent skin infections (HP:0001581) | 2.90187001 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.89582556 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88867745 |
| 57 | Obstructive lung disease (HP:0006536) | 2.88867745 |
| 58 | Leukocytosis (HP:0001974) | 2.84995413 |
| 59 | Increased IgE level (HP:0003212) | 2.82224981 |
| 60 | Amyloidosis (HP:0011034) | 2.80490808 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.80252780 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.74398741 |
| 63 | Increased serum ferritin (HP:0003281) | 2.72846421 |
| 64 | Abnormality of DNA repair (HP:0003254) | 2.72783076 |
| 65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.72647001 |
| 66 | Abnormal hair whorl (HP:0010721) | 2.66058137 |
| 67 | Eosinophilia (HP:0001880) | 2.65241118 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.64960629 |
| 69 | Meningitis (HP:0001287) | 2.64528634 |
| 70 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.62404368 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.62033781 |
| 72 | Gingivitis (HP:0000230) | 2.59990928 |
| 73 | Febrile seizures (HP:0002373) | 2.57963830 |
| 74 | Joint swelling (HP:0001386) | 2.56531756 |
| 75 | Nuclear cataract (HP:0100018) | 2.53813940 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.52844763 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.50485652 |
| 78 | Hematochezia (HP:0002573) | 2.46626285 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.44902272 |
| 80 | Chromsome breakage (HP:0040012) | 2.41374984 |
| 81 | Petechiae (HP:0000967) | 2.40926263 |
| 82 | B lymphocytopenia (HP:0010976) | 2.39439808 |
| 83 | Abnormality of B cell number (HP:0010975) | 2.39439808 |
| 84 | Abnormality of the nasal mucosa (HP:0000433) | 2.39294258 |
| 85 | Glomerulonephritis (HP:0000099) | 2.36816781 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.35412697 |
| 87 | Purpura (HP:0000979) | 2.34641782 |
| 88 | Arterial thrombosis (HP:0004420) | 2.34393960 |
| 89 | Keratitis (HP:0000491) | 2.34082732 |
| 90 | IgM deficiency (HP:0002850) | 2.33090168 |
| 91 | Granulocytopenia (HP:0001913) | 2.33050011 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.32388699 |
| 93 | Abnormality of macrophages (HP:0004311) | 2.29100858 |
| 94 | Urticaria (HP:0001025) | 2.28150708 |
| 95 | Progressive neurologic deterioration (HP:0002344) | 2.27511878 |
| 96 | Nasal polyposis (HP:0100582) | 2.27401215 |
| 97 | Encephalitis (HP:0002383) | 2.26553971 |
| 98 | Chronic sinusitis (HP:0011109) | 2.26537787 |
| 99 | Agammaglobulinemia (HP:0004432) | 2.25885814 |
| 100 | Gastrointestinal infarctions (HP:0005244) | 2.24674625 |
| 101 | Metaphyseal irregularity (HP:0003025) | 2.22439574 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21602989 |
| 103 | Supranuclear gaze palsy (HP:0000605) | 2.20930605 |
| 104 | Spondylolisthesis (HP:0003302) | 2.19400016 |
| 105 | Abnormality of the fingertips (HP:0001211) | 2.18282141 |
| 106 | Polyneuropathy (HP:0001271) | 2.17547288 |
| 107 | Diminished motivation (HP:0000745) | 2.16463566 |
| 108 | Apathy (HP:0000741) | 2.15120934 |
| 109 | Myocardial infarction (HP:0001658) | 2.12751202 |
| 110 | Gastrointestinal stroma tumor (HP:0100723) | 2.12743069 |
| 111 | Vertebral compression fractures (HP:0002953) | 2.10307026 |
| 112 | Hypoplasia of the thymus (HP:0000778) | 2.09475916 |
| 113 | Abnormality of the prostate (HP:0008775) | 2.08677095 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 2.08424340 |
| 115 | Prostate neoplasm (HP:0100787) | 2.07754546 |
| 116 | Gangrene (HP:0100758) | 2.07635448 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 2.07350835 |
| 118 | Hypoproteinemia (HP:0003075) | 2.06025202 |
| 119 | Restrictive lung disease (HP:0002091) | 2.04229876 |
| 120 | Prolonged neonatal jaundice (HP:0006579) | 2.03988212 |
| 121 | Premature loss of primary teeth (HP:0006323) | 2.02696119 |
| 122 | Abnormality of T cell physiology (HP:0011840) | 2.02315382 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 2.01698307 |
| 124 | Recurrent sinusitis (HP:0011108) | 2.00610058 |
| 125 | Agnosia (HP:0010524) | 1.97677391 |
| 126 | Clubbing of toes (HP:0100760) | 1.97162541 |
| 127 | Interstitial pulmonary disease (HP:0006530) | 1.96172352 |
| 128 | Parakeratosis (HP:0001036) | 1.96124991 |
| 129 | Flat occiput (HP:0005469) | 1.94938606 |
| 130 | Abnormality of the endocardium (HP:0004306) | 1.90822107 |
| 131 | Arthralgia (HP:0002829) | 1.90125910 |
| 132 | Ectropion (HP:0000656) | 1.88419352 |
| 133 | Basal ganglia calcification (HP:0002135) | 1.88115554 |
| 134 | Recurrent pneumonia (HP:0006532) | 1.87539927 |
| 135 | Anorexia (HP:0002039) | 1.84980578 |
| 136 | Personality changes (HP:0000751) | 1.84058188 |
| 137 | Abnormality of incisor morphology (HP:0011063) | 1.81307692 |
| 138 | Anhidrosis (HP:0000970) | 1.79919749 |
| 139 | Lymphoma (HP:0002665) | 1.79824751 |
| 140 | Stomach cancer (HP:0012126) | 1.79455843 |
| 141 | Bronchitis (HP:0012387) | 1.79305967 |
| 142 | Abnormality of the renal collecting system (HP:0004742) | 1.78397083 |
| 143 | Duplicated collecting system (HP:0000081) | 1.77596170 |
| 144 | Conical tooth (HP:0000698) | 1.76967388 |
| 145 | Bronchiectasis (HP:0002110) | 1.76623035 |
| 146 | Focal motor seizures (HP:0011153) | 1.73581882 |
| 147 | Hypothermia (HP:0002045) | 1.73421241 |
| 148 | Periodontitis (HP:0000704) | 1.72143508 |
| 149 | Glomerulopathy (HP:0100820) | 1.71082217 |
| 150 | Inflammation of the large intestine (HP:0002037) | 1.69948585 |
| 151 | Recurrent otitis media (HP:0000403) | 1.69193964 |
| 152 | Ectopic kidney (HP:0000086) | 1.68647768 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.68596490 |
| 154 | Absent/shortened dynein arms (HP:0200106) | 1.68596490 |
| 155 | Abnormality of male internal genitalia (HP:0000022) | 1.65539872 |
| 156 | IgA deficiency (HP:0002720) | 1.64785166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.31879725 |
| 2 | MAP3K14 | 4.18533275 |
| 3 | IKBKE | 3.67580084 |
| 4 | MAP4K1 | 3.02595661 |
| 5 | JAK3 | 2.93704145 |
| 6 | TBK1 | 2.77175679 |
| 7 | CASK | 2.57141944 |
| 8 | ERN1 | 2.55832940 |
| 9 | SIK3 | 2.43416567 |
| 10 | TNIK | 2.37336690 |
| 11 | TYK2 | 2.33767960 |
| 12 | TGFBR2 | 2.25745571 |
| 13 | IRAK4 | 2.16972811 |
| 14 | FGR | 2.16225675 |
| 15 | PRPF4B | 2.09468175 |
| 16 | MATK | 2.05629431 |
| 17 | IKBKB | 2.03467718 |
| 18 | MAP3K11 | 1.98548901 |
| 19 | ITK | 1.94938733 |
| 20 | DDR2 | 1.91467527 |
| 21 | JAK1 | 1.88253793 |
| 22 | TESK2 | 1.87923160 |
| 23 | ZAP70 | 1.86353449 |
| 24 | MAP3K13 | 1.84728951 |
| 25 | MAP3K12 | 1.72332513 |
| 26 | TEC | 1.70897161 |
| 27 | FGFR3 | 1.60281364 |
| 28 | CAMKK2 | 1.57624433 |
| 29 | MST4 | 1.56908300 |
| 30 | LCK | 1.56680967 |
| 31 | TESK1 | 1.50557614 |
| 32 | MAP3K3 | 1.48951857 |
| 33 | MAP2K3 | 1.46972763 |
| 34 | NLK | 1.44107364 |
| 35 | ADRBK2 | 1.38466839 |
| 36 | FGFR4 | 1.35034091 |
| 37 | KIT | 1.34900069 |
| 38 | CHUK | 1.34898478 |
| 39 | TAOK2 | 1.34071185 |
| 40 | MAP2K7 | 1.31984304 |
| 41 | BMPR2 | 1.23042740 |
| 42 | SYK | 1.21711077 |
| 43 | MOS | 1.21198191 |
| 44 | IRAK3 | 1.17924288 |
| 45 | HCK | 1.17063749 |
| 46 | CDC42BPA | 1.16196575 |
| 47 | CSF1R | 1.08017207 |
| 48 | RIPK4 | 1.07358061 |
| 49 | NTRK2 | 1.04004474 |
| 50 | CAMKK1 | 1.00052635 |
| 51 | PRKCQ | 0.99831506 |
| 52 | SGK2 | 0.99152357 |
| 53 | PRKCH | 0.97502317 |
| 54 | GRK7 | 0.96164091 |
| 55 | BLK | 0.95511294 |
| 56 | SIK2 | 0.95472241 |
| 57 | LIMK1 | 0.94006563 |
| 58 | BTK | 0.92124971 |
| 59 | IRAK1 | 0.92093786 |
| 60 | TNK2 | 0.92031810 |
| 61 | MKNK2 | 0.90167124 |
| 62 | ABL2 | 0.89783472 |
| 63 | YES1 | 0.86892754 |
| 64 | MUSK | 0.86638386 |
| 65 | CSK | 0.85830061 |
| 66 | MAP3K1 | 0.83871910 |
| 67 | ACVR1B | 0.82385419 |
| 68 | FES | 0.80053248 |
| 69 | LYN | 0.78739568 |
| 70 | NEK6 | 0.77744154 |
| 71 | CDK9 | 0.76540738 |
| 72 | STK10 | 0.76241799 |
| 73 | MAPK13 | 0.76223561 |
| 74 | BCR | 0.75717254 |
| 75 | EPHB1 | 0.75437522 |
| 76 | RIPK1 | 0.71093465 |
| 77 | PKN1 | 0.70494773 |
| 78 | BMPR1B | 0.70427835 |
| 79 | EPHA3 | 0.68555540 |
| 80 | ARAF | 0.67174042 |
| 81 | MAPK7 | 0.66845778 |
| 82 | SGK3 | 0.66610330 |
| 83 | CLK1 | 0.66584408 |
| 84 | ZAK | 0.65895305 |
| 85 | MAP2K6 | 0.65286749 |
| 86 | MAP2K2 | 0.63846200 |
| 87 | CAMK1D | 0.62964601 |
| 88 | PIM1 | 0.61719713 |
| 89 | IRAK2 | 0.60504665 |
| 90 | TYRO3 | 0.58226748 |
| 91 | PIM2 | 0.56859828 |
| 92 | MAP3K5 | 0.56188771 |
| 93 | NME2 | 0.53525403 |
| 94 | KDR | 0.53444426 |
| 95 | CDK3 | 0.52819985 |
| 96 | JAK2 | 0.51063424 |
| 97 | PDK1 | 0.50749989 |
| 98 | AKT3 | 0.50090012 |
| 99 | GRK6 | 0.50039124 |
| 100 | MARK3 | 0.49202959 |
| 101 | NUAK1 | 0.48878135 |
| 102 | TRPM7 | 0.48234765 |
| 103 | RPS6KC1 | 0.48043069 |
| 104 | RPS6KL1 | 0.48043069 |
| 105 | PDPK1 | 0.46461776 |
| 106 | EIF2AK2 | 0.43950574 |
| 107 | SIK1 | 0.43430722 |
| 108 | MAPK4 | 0.42694688 |
| 109 | SGK223 | 0.42655910 |
| 110 | SGK494 | 0.42655910 |
| 111 | RPS6KA2 | 0.42456365 |
| 112 | NEK9 | 0.42041523 |
| 113 | SGK1 | 0.41957355 |
| 114 | HIPK2 | 0.41781871 |
| 115 | MAP3K6 | 0.41548551 |
| 116 | CDK8 | 0.40914642 |
| 117 | STK16 | 0.40744507 |
| 118 | IGF1R | 0.40742738 |
| 119 | PDGFRA | 0.40508323 |
| 120 | PRKCD | 0.39995552 |
| 121 | RPS6KA6 | 0.38158261 |
| 122 | MARK2 | 0.38148821 |
| 123 | STK24 | 0.38130908 |
| 124 | MAPKAPK2 | 0.37700846 |
| 125 | NTRK3 | 0.37676662 |
| 126 | TTN | 0.35936361 |
| 127 | TAOK3 | 0.33089300 |
| 128 | PAK4 | 0.32932071 |
| 129 | MAP3K7 | 0.31923482 |
| 130 | MAPK3 | 0.31188110 |
| 131 | PRKCE | 0.30625217 |
| 132 | PRKD2 | 0.29833346 |
| 133 | FYN | 0.29552642 |
| 134 | TAOK1 | 0.29138462 |
| 135 | PDGFRB | 0.28962961 |
| 136 | CDK6 | 0.28721263 |
| 137 | MAPK12 | 0.27741641 |
| 138 | ABL1 | 0.27330781 |
| 139 | CDK4 | 0.27301902 |
| 140 | TGFBR1 | 0.26237436 |
| 141 | EPHA4 | 0.24678182 |
| 142 | BRD4 | 0.23904127 |
| 143 | SRPK1 | 0.23634536 |
| 144 | TLK1 | 0.22819695 |
| 145 | INSR | 0.21705804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.78182145 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41033866 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.29635188 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.13962660 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.71079324 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64162577 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.62174644 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.59880583 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.48169811 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.44915978 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.36664229 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22496843 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09585993 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.07737403 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05749704 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.97569516 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95398808 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84660156 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.70035472 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67843502 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66672183 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62580110 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61941238 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57647966 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57255936 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.45267679 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41419729 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38775789 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38754793 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.29042507 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26694282 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.22700233 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.21720820 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14496358 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.13843891 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.09001047 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04730760 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00875615 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98781650 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 0.98592750 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98587308 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97589509 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 0.94596483 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.93971494 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.93102092 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89634828 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88502159 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88491521 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.85539471 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.82957005 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.82681063 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81702577 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80341701 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.77757881 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77384131 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77365448 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77250145 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.76588866 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75680077 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75007687 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.72697648 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.70050781 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69868267 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69496805 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68372053 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65324572 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65297888 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65167258 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63218135 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62258258 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59734074 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59555011 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59142481 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59048948 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58708301 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.56879623 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55919728 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53442571 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52689406 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52519219 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51597135 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.51354269 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.50882471 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50158079 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49459227 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49386108 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48904750 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44810381 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43535368 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43493576 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42150000 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41839951 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38800752 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38472784 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38392445 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37286395 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36806995 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36629710 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36603836 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36587740 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36319327 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36165751 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34947892 |
| 104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34892183 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34097040 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33875282 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32658175 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32070858 |
| 109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30978325 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30918314 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30681796 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30578577 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30494532 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30484716 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30289064 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30084801 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29376197 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27744170 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.27102400 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27042415 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.26921807 |
| 122 | RNA degradation_Homo sapiens_hsa03018 | 0.25037300 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24760542 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23892744 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22790192 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.21365448 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18190568 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16441651 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15847253 |
| 130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.14227626 |

